F.F. Vajdos

8.6k total citations · 4 hit papers
20 papers, 6.1k citations indexed

About

F.F. Vajdos is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, F.F. Vajdos has authored 20 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Immunology. Recurrent topics in F.F. Vajdos's work include Protein Structure and Dynamics (4 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Signaling Pathways in Disease (3 papers). F.F. Vajdos is often cited by papers focused on Protein Structure and Dynamics (4 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Signaling Pathways in Disease (3 papers). F.F. Vajdos collaborates with scholars based in United States, Germany and United Kingdom. F.F. Vajdos's co-authors include Gerald R. Grimsley, C. Nick Pace, Lanette Fee, Wesley I. Sundquist, Christopher P. Hill, Abraham M. de Vos, Sanghee Yoo, David K. Worthylake, Theresa Gamble and Matthew C. Franklin and has published in prestigious journals such as Science, Cell and Journal of Biological Chemistry.

In The Last Decade

F.F. Vajdos

20 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

How to measure and predict the molar absorption coefficient of a protein

1995 3.4k citations C. Nick Pace, F.F. Vajdos et al. Protein Science profile →
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex

2004 828 citations Matthew C. Franklin, Kendall D. Carey et al. Cancer Cell profile →
Crystal Structure of Human Cyclophilin A Bound to the Amino-Terminal Domain of HIV-1 Capsid

1996 597 citations Theresa Gamble, F.F. Vajdos et al. Cell profile →
Structure of the Carboxyl-Terminal Dimerization Domain of the HIV-1 Capsid Protein

1997 514 citations Theresa Gamble, Sanghee Yoo et al. Science profile →

Peers

Countries citing papers authored by F.F. Vajdos

Since Specialization

Citations

This map shows the geographic impact of F.F. Vajdos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.F. Vajdos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.F. Vajdos more than expected).

Fields of papers citing papers by F.F. Vajdos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.F. Vajdos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.F. Vajdos. The network helps show where F.F. Vajdos may publish in the future.

Co-authorship network of co-authors of F.F. Vajdos

This figure shows the co-authorship network connecting the top 25 collaborators of F.F. Vajdos. A scholar is included among the top collaborators of F.F. Vajdos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.F. Vajdos. F.F. Vajdos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Macrocyclic Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonists 2023 ·ACS Medicinal Chemistry Letters ·Mark E. Schnute, John I. Trujillo, Katherine L. Lee, Ray Unwalla, F.F. Vajdos, Björn Kauppi, Philippe Nuhant, Andrew C. Flick, (unknown), Yajuan Zhao, (unknown), (unknown), Alexandria P. Taylor, Amy Brault, John D. Knafels, Michael L. Vazquez, Gabriel Berstein	3
2	Demonstration of In Vitro to In Vivo Translation of a TYK2 Inhibitor That Shows Cross Species Potency Differences 2020 ·Scientific Reports ·Brian S. Gerstenberger, Mary Ellen Banker, James D. Clark, Martin E. Dowty, Andrew Fensome, (unknown), Matthew C. Griffor, Martin Hegen, Brett D. Hollingshead, John D. Knafels, Tsung H. Lin, James F. Smith, F.F. Vajdos	7
3	Discovery of Potent and Selective Periphery-Restricted Quinazoline Inhibitors of the Cyclic Nucleotide Phosphodiesterase PDE1 2018 ·Journal of Medicinal Chemistry ·John M. Humphrey, Matthew A. Movsesian, Christopher W. am Ende, Stacey L. Becker, Thomas A. Chappie, Stephen Jenkinson, Jennifer L. Liras, Spiros Liras, Christine C. Orozco, Jayvardhan Pandit, F.F. Vajdos, Fabrice Vandeput, (unknown), Frank S. Menniti	24
4	Decreasing the Rate of Metabolic Ketone Reduction in the Discovery of a Clinical Acetyl-CoA Carboxylase Inhibitor for the Treatment of Diabetes 2014 ·Journal of Medicinal Chemistry ·David A. Griffith, Daniel W. Kung, William P. Esler, Paul A. Amor, Scott W. Bagley, Carine Beysen, Santos Carvajal‐Gonzalez, Shawn D. Doran, Chris Limberakis, Alan M. Mathiowetz, (unknown), David A. Price, Éric Ravussin, Gabriele E. Sonnenberg, (unknown), Laurel J. Sweet, Scott Turner, F.F. Vajdos	60
5	Small-molecule phosphodiesterase probes: discovery of potent and selective CNS-penetrable quinazoline inhibitors of PDE1 2014 ·MedChemComm ·John M. Humphrey, (unknown), Christopher W. am Ende, Eric P. Arnold, (unknown), Stephen Jenkinson, Lorraine A. Lebel, Spiros Liras, Jayvardhan Pandit, Brian Samas, F.F. Vajdos, Samuel P. Simons, A.G. Evdokimov, Mahmoud N. Mansour, Frank S. Menniti	31
6	Spirocyclic Sulfamides as β-Secretase 1 (BACE-1) Inhibitors for the Treatment of Alzheimer’s Disease: Utilization of Structure Based Drug Design, WaterMap, and CNS Penetration Studies To Identify Centrally Efficacious Inhibitors 2012 ·Journal of Medicinal Chemistry ·Michael A. Brodney, Gabriela Barreiro, Kevin Ogilvie, Éva Hajós‐Korcsok, John C. Murray, F.F. Vajdos, Claude Ambroise, Curt Christoffersen, Katherine Fisher, Lorraine F. Lanyon, Jianhua Liu, Charles E. Nolan, Jane M. Withka, Kris A. Borzilleri, Ivan Efremov, Christine Oborski, Alison E. Varghese, Brian T. O’Neill	44
7	Deconstruction of Activity-Dependent Covalent Modification of Heme in Human Neutrophil Myeloperoxidase by Multistage Mass Spectrometry (MS⁴) 2012 ·Biochemistry ·Kieran F. Geoghegan, Alison H. Varghese, Xidong Feng, (unknown), James J. Conboy, Roger B. Ruggeri, Kay Ahn, (unknown), Sergey V. Filippov, (unknown), Philip A. Carpino, Cristiano R. W. Guimarães, F.F. Vajdos	15
8	Discovery and Optimization of a Novel Spiropyrrolidine Inhibitor of β-Secretase (BACE1) through Fragment-Based Drug Design 2012 ·Journal of Medicinal Chemistry ·Ivan Efremov, F.F. Vajdos, Kris A. Borzilleri, S.H. Capetta, Hou Chen, Peter H. Dorff, Jason K. Dutra, Steven W. Goldstein, Mahmoud N. Mansour, Alexander S. McColl, Stephen Noell, Christine Oborski, Thomas N. O’Connell, Theresa J. O’Sullivan, Jayvardhan Pandit, Hong Wang, BinQing Wei, Jane M. Withka	50
9	Structure-guided Inhibitor Design for Human Acetyl-coenzyme A Carboxylase by Interspecies Active Site Conversion 2011 ·Journal of Biological Chemistry ·Francis Rajamohan, Eric S. Marr, Allan R. Reyes, James A. Landro, Marie Anderson, Jeffrey W. Corbett, Kenneth J. DiRico, (unknown), Meihua Tu, F.F. Vajdos	5
10	The 2.0 Å crystal structure of the ERα ligand‐binding domain complexed with lasofoxifene 2007 ·Protein Science ·F.F. Vajdos, Lise R. Hoth, Kieran F. Geoghegan, Samuel P. Simons, Peter K. LeMotte, Dennis E. Danley, Mark Ammirati, Jayvardhan Pandit	46
11	Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex breakdown → 2004 ·Cancer Cell ·Matthew C. Franklin, Kendall D. Carey, F.F. Vajdos, Daniel J. Leahy, Abraham M. de Vos, Mark X. Sliwkowski	828
12	Suppressor of Fused Regulates Gli Activity through a Dual Binding Mechanism 2004 ·Molecular and Cellular Biology ·Mark Merchant, F.F. Vajdos, Mark Ultsch, Henry R. Maun, U. Wendt, (unknown), William Desmarais, Robert A. Lazarus, Abraham M. de Vos, Frédéric J. de Sauvage	98
13	Structural insights into the catalytic mechanism of cyclophilin A 2003 ·Nature Structural & Molecular Biology ·B.R. Howard, F.F. Vajdos, Sam Li, Wesley I. Sundquist, Christopher P. Hill	128
14	Comprehensive Functional Maps of the Antigen-binding Site of an Anti-ErbB2 Antibody Obtained with Shotgun Scanning Mutagenesis 2002 ·Journal of Molecular Biology ·F.F. Vajdos, Camellia Adams, (unknown), Leonard G. Presta, Abraham M. de Vos, Sachdev S. Sidhu	97
15	Crystal Structure of Human Insulin-like Growth Factor-1: Detergent Binding Inhibits Binding Protein Interactions 2001 ·Biochemistry ·F.F. Vajdos, Mark Ultsch, (unknown), Kurt Deshayes, Jun Liu, Nicholas J. Skelton, Abraham M. de Vos	75
16	Crystal structure of cyclophilin A complexed with a binding site peptide from the HIV‐1 capsid protein 1997 ·Protein Science ·F.F. Vajdos, Sanghee Yoo, (unknown), Wesley I. Sundquist, Christopher P. Hill	82
17	Structure of the Carboxyl-Terminal Dimerization Domain of the HIV-1 Capsid Protein breakdown → 1997 ·Science ·Theresa Gamble, Sanghee Yoo, F.F. Vajdos, Uta K. von Schwedler, David K. Worthylake, Hui Wang, John P. McCutcheon, Wesley I. Sundquist, Christopher P. Hill	514
18	Crystal Structure of Human Cyclophilin A Bound to the Amino-Terminal Domain of HIV-1 Capsid breakdown → 1996 ·Cell ·Theresa Gamble, F.F. Vajdos, Sanghee Yoo, David K. Worthylake, (unknown), Wesley I. Sundquist, Christopher P. Hill	597
19	How to measure and predict the molar absorption coefficient of a protein breakdown → 1995 ·Protein Science ·C. Nick Pace, F.F. Vajdos, Lanette Fee, Gerald R. Grimsley, (unknown)	3392
20	Pseudomonas cepacia 2,2-dialkylglycine decarboxylase. Sequence and expression in Escherichia coli of structural and repressor genes. 1990 ·Journal of Biological Chemistry ·John W. Keller, (unknown), (unknown), (unknown), (unknown), (unknown), Lars O.E. Ebbesson, F.F. Vajdos	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact